A histidine-based amphiphilic peptide (P) has been
found to form an injectable transparent hydrogel in phosphate buffer
solution over a pH range from 7.0 to 8.5 with an inherent antibacterial
property. It also formed a hydrogel in water at pH = 6.7. The peptide
self-assembles into a nanofibrillar network structure which is characterized
by high-resolution transmission electron microscopy, field-emission
scanning electron microscopy, atomic force microscopy, small-angle
X-ray scattering, Fourier-transform infrared spectroscopy, and wide-angle
powder X-ray diffraction. The hydrogel exhibits efficient antibacterial
activity against both Gram-positive bacteria Staphylococcus
aureus (S. aureus)
and Gram-negative bacteria Escherichia coli (E. coli). The minimum inhibitory
concentration of the hydrogel ranges from 20 to 100 μg/mL. The
hydrogel is capable of encapsulation of the drugs naproxen (a non-steroidal
anti-inflammatory drug), amoxicillin (an antibiotic), and doxorubicin,
(an anticancer drug), but, selectively and sustainably, the gel releases
naproxen, 84% being released in 84 h and amoxicillin was released
more or less in same manner with that of the naproxen. The hydrogel
is biocompatible with HEK 293T cells as well as NIH (mouse fibroblast
cell line) cells and thus has potential as a potent antibacterial
and drug releasing agent. Another remarkable feature of this hydrogel
is its magnification property like a convex lens.